Medindia
Medindia LOGIN REGISTER
Advertisement

MarketsandMarkets: Global Stem Cell and Advanced Technologies Market Worth US$ 88.3 Billion By 2014

Wednesday, November 4, 2009 General News
Advertisement
WILMINGTON, Delaware, November 3 The new market researchreport, 'Global Stem Cell and Advanced Technologies Market' (2009 - 2014)',published by MarketsandMarkets (http://www.marketsandmarkets.com) analyzesthe major trends in the global stem cell market. It identifies and analyzesthe main market drivers, restraints, and opportunities for the variousproducts, services, technologies, and applications submarkets in differentgeographic regions.
Advertisement

Browse in-depth TOC on stem cell market. Early buyers will receive 10%customization of report.

http://www.marketsandmarkets.com/Market-Reports/stem-cell-technologies-an
Advertisement

d-global-market-48.html

(Due to the length of this URL, it may be necessary to copy and paste thehyperlink into your Internet browser's URL address field. Remove the space ifone exists.)

The stem cell market is growing rapidly due to increasing regulatoryapproval and public acceptance bodies. The benefits of stem cell therapy areattracting an increasing number of patients. The product submarket for humanand embryo stem cells are expected to drive the growth of the overall market.In addition, intensive R&D efforts and the increasing investments intoresearch on stem cells therapy are soon expected to improve the efficacy ofstem cell treatment. However, the high cost of the therapy may affect marketgrowth.

The global stem cell market is estimated to be $88.3 billion by 2014,growing at a CAGR of 14.8 % from 2009 to 2014. The U.S. currently holds a 60%share of the global stem cell market; and forms an especially lucrativemarket for areas such as bone marrow transplantation through stem cells. Thisresearch report will help stakeholders gain a better understanding of productpricing and regulatory framework governing the dynamics of the stem cellmarket. The key players in the market include Osiris Therapeutics, StemTronix Inc., Stemcell Technologies, Genzyme Corp., Cytori, and Geron.

Analyst Briefing Presentation on the Global Stem Cells Market to be heldon 18th November, 2009

The Healthcare practice at MarketsandMarkets is pleased to announce itsAnalyst Briefing Presentation on the Global Stem Cells Market to be held on18th November, 2009.

To register your participation, please click here

http://www.marketsandmarkets.com/AnalystBriefing/stem-cells-market.asp

About MarketsandMarkets

MarketsandMarkets is a research and consulting firm that publishes 120market research reports per year. Each strategically analyzed report containsin-depth, five-level segmentation for each of the products, services,applications, technologies, ingredients and stakeholders categories. Ourreports also analyze about 200 patents, over 40 companies and micro marketsthat are mutually exclusive and collectively exhaustive. Browse all our 120titles at http://www.marketsandmarkets.com.Market Estimates and Forecasts The report categorizes the global stem cell market as follows: - Stem Cell Products (adult stem cell, human embryonic stem cell, and other stem cell types) - Stem Cell Services (stem cell banking, stem cell acquisition and testing, drug discovery and target identification, isolation/characterization services, and molecular biology ) - Stem Cell Technologies (stem cell acquisition, stem cell production, cryopreservation, and expansion and subculture) - Stem Cell Applications (regenerative medicine - neurological disorders, orthopedics, cancer, hematological disorders, myocardial infarction and cardiovascular diseases, injuries, diabetes, liver disorder, incontinence, and drug development)

SOURCE Markets and Markets
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close